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Abstract
Background: Several research groups from different European countries have worked on the aetiopathogenesis
of bovine neonatal pancytopenia (BNP) and an association between the use of the vaccine PregSure BVD
(Pfizer, Germany) and the development of this haemorrhagic disease was confirmed. Because BNP is not a
notifiable disease, it is difficult to obtain information on its incidence. Based on pharmacovigilance (PhV)
data, which are the only officially available data at the national level, the incidence of BNP is considered
low. However, voluntary reporting of the disease can lead to underreporting.
To gain more insight into the incidence of BNP among the affected herds, an epidemiological study was
performed, which focused on 243 farms in Germany with cases of BNP. Farmers were asked to report the
occurrence of BNP, including the number of cases, which allowed calculation of incidence in the affected
herds. Matching such data with the registered cases in the National PhV System (NPhVS) gave us an
opportunity to assess the extent of BNP underreporting.
Results: On 243 farms, a total of 1195 calves younger than 4 weeks with haemorrhagic diathesis were
registered. In 58 % of the reports, a diagnosis of BNP was confirmed by blood analysis and or by necropsy.
The number of cases observed on individual farms ranged from 1 to 80. Based on these results, the incidence
of BNP on affected farms ranged from 0.3 to 15.2 % (median 2.9 %). The maximal incidence in the year with
the highest number of BNP calves ranged between 0.4 and 18.6 % (median 3.3 %). Comparing the number of
cases registered in the NPhVS to the numbers found in this study revealed considerable underreporting to the
national database: only 44 % of the farms and 41 % of the BNP calves included in the study were registered
in the NPhVS.
Conclusions: In spite of the opportunity to report BNP calves to the Paul-Ehrlich-Institut (Langen, Germany),
the estimated number of undetected BNP cases is remarkably high. However, even if the revealed substantial
underreporting is taken into account, the incidence of BNP is low. Nevertheless, the incidence on some
affected farms is very high, resulting in considerable financial losses that should not be underestimated.
Although the exact pathomechanism of BNP at the molecular level is still not known, its incidence is clearly
declining following withdrawal of PregSure BVD from the market.
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Background
First cases of bovine neonatal pancytopenia (BNP) were
reported in Germany in 2006 and then in several other
European countries and New Zealand [1]. The work of
several research groups in various European countries
has yielded important information about the aetiology
and pathogenesis:
The consumption of colostrum-containing alloreactive
antibodies plays a crucial role in the development of
BNP [2, 3]. Vaccination against bovine viral diarrhoea
virus (BVDV) was suspected to be correlated with the
pathogenesis of BNP [4]. Intensive investigations identified
the inactivated vaccine PregSure BVD (Pfizer, Germany)
as a major risk factor for developing BNP [5–7]. In
some cows, the PregSure BVD vaccine induces allore-
active antibodies that target antigens derived from bovine
cells used for vaccine production [8]. Owing to the
consumption of colostrum from these cows, some calves
and foster calves develop thrombocytopenia, leukocyto-
penia, and panmyelophthisis [8–10]. As a consequence,
affected calves show bleeding symptoms and most often,
immunosuppression [2, 11, 12]. Owing to the absence of a
promising therapy for BNP, only about 10 % of affected
calves survive [4, 10, 11]. A subclinical course of the
disease has been described [13]. The most important
differential diagnoses for the clinical signs of BNP are the
haemorrhagic form of BVD (type 2), a severe septicaemia,
and other haemorrhagic diatheses. The haemorrhagic
form of BVD is very uncommon in Germany; in 95 % of
BVDV infections, the virus is type 1 [14]. Furthermore,
bleeding disorders of cattle are relatively rare. If these
disorders occur, they generally happen not only in calves
within the first 4 weeks of age, but at all ages. No other
haemorrhagic diatheses show similar processes to BNP
[15]. Classic septicaemia affects newborn calves between 2
and 6 days of age, and is attributed to other diseases.
Bleeding signs in septicaemic calves are possibly due to
capillary fragility or thrombocytopenia, but they are less
typical signs [16].
There is a remarkable difference in the incidence of
BNP among different regions within a country [17].
In addition to this geographical difference, the number
of cases per herd also varies [2, 4, 12]. BNP is not a
notifiable disease and, therefore, exact figures about
its occurrence are not available. Because the occur-
rence of BNP is believed to be related to the use of a
vaccine, each case should be reported as a possible
adverse event within the pharmacovigilance (PhV)
scheme. Veterinary surgeons and farmers have the
opportunity to report BNP cases to their national
competent authority, which for Germany, is the Paul-
Ehrlich-Institut in Langen. The agency recorded 4623
cases in Europe (date of download: 28.02.2011), in-
cluding 3040 cases from Germany..
However, there is currently no information available
as to what degree these numbers truly reflect the BNP
incidence. Furthermore, little information exists about
the incidence within an individual herd; most often,
the information is based on investigations on single
farms. According to reported results, within-herd inci-
dence are no higher than 10 % [8].
The aim of our study was to provide an overview of
the occurrence of BNP based on 243 affected farms in
Germany. The incidence of BNP was calculated and the
data of this study were compared with cases registered
in the National PhV System (NPhVS) to identify to what
extent BNP cases were reported within the PhV scheme.
Methods
Participating farms
Since the first case of BNP, affected calves have been
registered in a database at the Clinic for Ruminants with
Ambulatory and Herd Health Services, LMU Munich
(Oberschleissheim, Germany). Calls to encourage
registration from all over Germany were published in
Deutsches Tieraerzteblatt, a journal of the German
Veterinary Association. The database included 310
farms on January 3, 2011. Farms were eligible as case
farms if they had one or more confirmed cases of BNP
by necropsy (panmyelophthisis) and or by blood analysis
(thrombocytopenia [less than 200 × 109 platelets (PLT)/L]
and leukocytopenia [less than 4 × 109 white blood cells
(WBC)/L]). Blood analyses were performed by the labo-
ratory of the Clinic for Ruminants with Ambulatory and
Herd Health Services, LMU Munich. Necropsies were
performed by one of the following institutions: Bavarian
Authority for Health and Food Safety in Oberschleißheim
or Erlangen, Bavarian Animal Health Service in Poing,
Institute of Veterinary Pathology, Center for Clinical
veterinary Medicine, LMU Munich or Animal Health
service in Fellbach, Baden-Wuerttemberg.
Twenty-seven farms were excluded, because the blood
analysis of affected calves with haemorrhagic diathesis
revealed only thrombocytopenia or leukocytopenia. Fur-
ther, farms which only reported on BNP calves without
any confirmed case, were excluded (n = 28). In total,
255 farms with at least one confirmed case of BNP
were selected from the database.
Interview
Farmers were interviewed by telephone between January
3 and March 31, 2011. The interviews were conducted
in a uniform fashion by one veterinarian (FR) at the
Clinic for Ruminants. The veterinarian was trained
prior to the interviews and instructed to avoid leading
questions. The following data were collected for the
years from 2005 to 2011:
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– Number of cows per year
– Number of calves born per year
– Breed
– Type of farm (dairy farm or beef farm)
– Number of observed calves younger than 4 weeks of
age with haemorrhagic diathesis each year
– Proportion of confirmed cases of calves with BNP
among the observed calves with haemorrhagic
diathesis
– Use of PregSure BVD.
One year was defined as the 12 month period from
the first of January until the 31st of December. During
the interview, the answers were recorded on paper. In
case that the herd manager needed more time to look
up the information, the farm was contacted a second
time. If the farmer did not have any information about
the vaccine that was used to vaccinate against BVDV,
the veterinarian was contacted. If the farm had changed
the veterinarian during the considered timeframe, the
former veterinarian was called to get the information
needed. Only farms that used PregSure BVD were
included in the analysis. The questionnaire is available
as Additional file 1.
Incidence of BNP at the herd level
The total incidence on each farm was calculated as:
Total incidence %ð Þ ¼ Number of BNP calves
Average number of calves born per year 
Years with observed BNP cases
 100
The considered time period for each farm was not
equal due to the fact that BNP occurred on some farms
over several years and on other farms only within 1 year.
The aim of the study was to evaluate the incidence of
BNP on farms while the disease was prevalent on the
farm. Using the calculation above, allowed the compari-
son of incidences across farms. In addition, the maximal
incidence was calculated, which was related to the year
with the highest number of calves with BNP on the
farm:
Maximal incidence %ð Þ ¼
Highest number of calves with BNP
in one specific year
Number calves born in that year
 100
Data matching between the NPhVS and the clinic for
ruminants
Data matching was used to compare the number of
farms and cases of BNP registered in the national PhV
database at the Paul-Ehrlich-Institut against the numbers
calculated in our study. Therefore, the first digits of the
postal zip codes and the initials of the farmers were
compared. Farms and cases not listed in the NPhVS
were counted.
Descriptive and statistical analyses
The geographical distribution of the farms affected by
BNP was illustrated in a map created in ArcGIS software
(ESRI, version 9.3). A descriptive statistical analysis was
conducted using Excel version 13.0 (Microsoft Inc.,
USA) and SPSS for Windows version 19 (SPSS Inc.,
USA). Binomial confidence intervals were calculated in
Excel using the method of Agresti and Coull [18].
Results
Participating farms
Two of the 255 contacted farmers were not willing to
give an interview and one farmer had stopped farming,
thus they were excluded from the analysis. Nine farms
were excluded, because the herd was either not vacci-
nated against BVDV or PregSure BVD was not used.
Finally, 243 farms could be included and farmers were
available and willing to participate in the study. The
veterinarians were always available to complete the data
about the occurrence of BNP calves and the vaccination
against BVDV, in case they were needed. Most of the
farms (n = 241) were dairy farms with 168 having
German Fleckvieh (70 %), 47 farms with Holstein-Frisian
(19 %), 12 farms with Brown Swiss (5 %), nine farms
with Red Holstein (4 %) and five farms with German
Fleckvieh crossbred (2 %). Two farmers had a cow-calf
operation with Limousin and German Fleckvieh, respec-
tively. The geographical distribution of the participating
farms is shown in Fig. 1. Of the 243 farms, 76 % were
located in Bavaria and 24 % were in eight other federal
states of Germany. The herd size ranged from 14 to
950 cows (average 67).
Total number of calves with haemorrhagic diathesis (four
weeks old or younger)
During the interviews, the 243 farmers reported 1195
newborn calves with a bleeding disorder occurring
between January 1, 2005, and March 31, 2011 (Fig. 2).
The first four cases were observed in 2005 on three
different farms. However, a remarkable increase in the
number of calves being observed with BNP was not
noted until 2008, when 253 cases were observed on
88 farms. The year 2009 had the highest number of
observed cases: 68 farms that had previously reported
BNP cases and 120 new farms were affected and recorded.
A total of 539 calves had clinical signs of haemorrhagic
diathesis during their first month of life. After 2009, the
number of cases declined on all participating farms.
Number of cases observed per farm
The number of newborn calves with haemorrhagic
diathesis on each farm is illustrated in Fig. 3, excluding
two farms with 50 and 80 cases, because they are
outliers.
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BNP cases were registered during only 1 year on
nearly one-half of the farms (44 %). Thirty-five percent
of the 241 farmers noted calves with BNP during two of
the years, 36 farmers during three of the year, and
another 12 farmers during four of the years. One inter-
viewed owner reported cases during 5 years and another
one during 6 years. Some farms had a year without
having calves with BNP between the years with cases of
BNP.
In 58 % of the registered cases, BNP was confirmed
either by blood analysis and or by necropsy. In 42 % of
the cases, farmers did not initiate an examination to
clarify the aetiology of the bleeding disorder.
Overall incidence and incidence of BNP at the herd level
The incidence could not be calculated for two farms,
because the farmers did not remember the exact distri-
bution of BNP calves over the years. Regarding the
Fig. 1 Geographical distribution of participating farms with bovine neonatal pancytopenia (BNP) (n = 243) The farms were listed in a database of
the Clinic for Ruminants with Ambulatory and Herd Health Services at the Centre for Clinical Veterinary Medicine, LMU Munich (Oberschleissheim,
Germany). At least one calf younger than four weeks of age was registered on each farm, with haemorrhagic diathesis that was confirmed as BNP
by blood analysis and or necropsy
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whole timeframe (January 1, 2005 to March 31, 2011),
the overall incidence of BNP on 243 farms added up to
1 %. In the year with the highest number of cases (2009),
the incidence across all farms was 2.8 %.
The incidence of BNP within the 241 farms ranged
between 0.3 and 15.2 % (median 2.9 %). The incidence
distribution is shown in Fig. 4. The maximal incidence
in the year with the highest number of BNP calves
ranged from 0.4 to 18.6 % (median 3.3 %). The diffe-
rence between the total incidence and the maximal inci-
dence was particularly marked on farms with BNP cases
scattered over several years, including 1 year with an
irregularly high number of calves with BNP. On some of
those farms, the maximal incidence was two to three
times higher than the total incidence throughout the
surveyed period.
Data matching between the NPhVS and the clinic for
ruminants
Data matching between the two databases revealed 701
of 1195 cases (59 %) were not registered in the NPhVS,
but were noted in the interviews conducted in our study.
A total of 137 of the 243 participating farms (56 %)
had not reported any cases to the NPhVS. Only 41 %
of the interviewed Bavarian farmers and only 33 % of
the 759 BNP calves from Bavaria in our study were
registered with the NPhVS. Ten of 12 farms from
Baden-Wuerttemberg reported their cases to the NPhVS,
Fig. 2 Number of observed cases of bovine neonatal pancytopenia (BNP) on 241 farms between 2005 and 2011. The study was finished on
March 31, 2011. BNP cases that occurred afterwards in 2011 were not recorded. BNP cases of two farms are not shown, because the exact
distribution of BNP calves over the years were not available
Fig. 3 Number of farms that have observed a particular number of bovine neonatal pancytopenia (BNP) cases between 2005 and March 2011.
One farm with 50 cases and another one with 80 are not included in the figure, because they are outliers
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but only 24 of 47 interviewed farmers from the other
federal states of Germany reported their cases. The data
matching results are shown in Table 1.
Discussion
Incidence of BNP at the herd level
One of the main objectives of this study was to identify
the incidence of BNP at the herd level. For the calcula-
tion of the incidence the average number of calves born
on the farm was available. This could have introduced a
bias, as stillborn calves would not have been included in
the denominator of the calculation. Using the average
number of calves born on the farm also could have
introduced a bias, which we cannot exclude. However,
all farmers included in the study had reported that their
herd size had been stable over the considered time
period, therefore we are confident that the number of
calves born over several years did not vary considerably.
BNP affects calves during their first 4 weeks of life. Male
Holstein-Frisian and Red Holstein calves are usually sold
at an age of two weeks, thus it is possible that some
cases of BNP were missed when BNP occurred after the
calves were sold to another farm. However, most of the
participating farms (77 %) had German Fleckvieh, cross-
bred or Brown Swiss. Male calves from those farms are
typically not sold before they have reached a certain age
or weight and do not leave the farm during the time
when BNP may occur.
The highest incidence reported in a herd from our
study (19 %) was substantially higher than the incidence
rates reported in other studies, which was up to only
10 % [8]. Although the BNP incidence was low on most
of the affected farms, some herds were obviously more
severely affected. The incidence of BNP varies markedly
among different countries and also among the federal
states of Germany [4, 6]. The farms enrolled in our study
were from nine federal states of Germany. However,
most of the farms with cases of BNP were localized in
Fig. 4 Within-herd incidence of bovine neonatal pancytopenia (BNP). The incidence was calculated using the number of BNP calves on 241
affected farms from January 1, 2005, to March 31, 2011. The rate ranged from 0.3 to 15.2 % (median 2.9 %). The incidence could not be
calculated for two farms, because the exact distribution of BNP cases over the years was not available
Table 1 Results of data matching between the Clinic for Ruminants with Ambulatory and Herd Health Services at the Centre for
Clinical Veterinary Medicine, LMU Munich (Oberschleissheim, Germany), and the National Pharmacovigilance System (NPhVS):
Comparison of bovine neonatal pancytopenia (BNP) farms and the number of BNP cases on those farms
Federal State Farms reported






registered farms in %
(Confidence Interval)
Total BNP cases
on the farms of
the LMU study
BNP cases on the





BNP cases in %
(Confidence Interval)
Bavaria 184 75 40.76 (33.92–47.98) 759 248 32.67 (29.43–36.09)
Baden-Wuerttemberg 12 10 83.33 (55.20–95.30) 67 54 80.6 (69.58–88.29)
Brandenburg 1 1 100.00 (20.65–100.00) 6 6 100 (60.97–100.00)
Hesse 5 4 80.00 (37.55–96.38) 47 7 14.89 (7.14–27.69)
Lower Saxony 1 0 0.00 (0.00–79.35) 2 0 0.00 (0.00–65.76)
North Rhine-Westphalia 26 14 53.85 (35.46–71.24) 242 133 54.96 (48.66–61.1)
Mecklenburg-Vorpommern 2 2 100.00 (34.24–100.00) 39 32 82.05 (67.33–91.02)
Schleswig-Holstein 6 3 50.00 (18.76–81.24) 19 9 47.37 (27.33–68.29)
Rhineland-Palatinate 6 0 0.00 (0.00–39.03) 14 0 0.00 (0.00–21.53)
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Bavaria. Kasonta et al. [17] investigated the influence of
different patterns of PregSure BVD vaccinations on the
incidence of BNP. Their data showed that different
vaccination regimens resulted in differences in alloreac-
tive antibody concentrations. Therefore, the differences
in incidence rates among federal states can potentially
be explained by the different vaccination protocols that
exist. Apart from the varying incidence among the
federal states of Germany, we found considerable differ-
ences among the participating farms within the federal
states. Presumably, the use of different vaccination regi-
mens at the herd level is the reason for that observation,
but other factors (e.g. colostrum management) could
have had an influence on the incidence as well.
The present study shows a remarkable increase of
BNP cases in 2008, reaching a peak in 2009. Although
PregSure BVD was licensed in 2004, an increased
BNP incidence was not noted until 2007. The same
phenomenon was observed in New Zealand: the first
cases of BNP occurred there in 2011, which was 3 years
after the introduction of PregSure BVD [19]. Kasonta et
al. [17] interpreted the temporal delay as being associated
with the repeated immunizations that are required for cre-
ating a titre of alloreactive antibodies high enough to in-
duce clinical BNP in the calves.
Various reasons exist for the decline of BNP cases on
farms in our study since 2010. Owing to increased
knowledge concerning aetiopathogenesis, farmers adapted
their management practices, especially colostrum and
vaccination management [20]. The safest way to prevent
further BNP cases is to dispose of colostrum coming from
known ‘BNP dams’ and to feed calves colostrum from
cows that have not been vaccinated with PregSure BVD.
Before PregSure BVD was withdrawn from the German
market in April 2010, many farmers had already switched
to a different BVD vaccine or discontinued vaccination
against the BVDV. Nevertheless, calves with BNP are still
observed on some farms, but in much smaller numbers
[21]. Therefore, the antibody titre seems to remain high
for a long time, even though PregSure BVD is no longer
used. It is uncertain how much longer further cases of
BNP will occur, but they will most likely stop when the
last PregSure BVD-vaccinated cows are removed.
Data matching between the two databases
Another objective of our study was to investigate
whether the number of calves with BNP registered at the
NPhVS reflects the real number of cases in Germany.
More than one-half of the cases and farms had not been
listed in the NPhVS database of the Paul-Ehrlich-
Institut. Three-hundred cases of BNP were reported in
our study that occurred before 2009, which was the year
when BNP was recognized as a potential serious adverse
effect of PregSure BVD. A retrospective report of these
cases was technically possible, but seems unlikely to
happen, so most of these cases are most likely not in the
database. Although veterinarians are requested to report
adverse events in accordance with the veterinary medical
association’s professional code of conduct, they and the
farmers do not directly benefit from reporting cases to
the NPhVS. Thus, they are increasingly reluctant to fill
in reporting questionnaires. Although we discovered a
remarkable extent of underreporting, considering the
population of 4.3 million dairy cows in Germany [22],
the overall incidence is still very low.
Economic relevance
The severity of economic losses in affected herds due to
medical treatments of BNP calves, costs for the veteri-
narian, and especially case fatalities, is difficult to esti-
mate. However, an appreciable pecuniary loss can be
assumed for farms with high incidence. In addition, less
obvious losses could be caused by subclinical BNP cases
in which calves could be more susceptible to other
diseases, especially infections due to immunosuppres-
sion. Thus, in an epidemiological study, 2.5 % of control
calves had thrombocytopenia and leucocytopenia with-
out clinical signs of BNP [15], and another research
group induced subclinical BNP in 20 % of calves after
feeding with colostrum from ‘BNP dams’ [23].
Confirmation of BNP via blood analysis or necropsy
To reduce the bias of misclassification and, thus,
maximize the probability of including farms with actual
cases, only farms with at least one confirmed case of
BNP were included in this study. Therefore, we excluded
some farms from the study because even though the
farmers had observed calves with signs consistent with
BNP within their herds, they did not initiate an exami-
nation to verify the aetiology.
As reflected by the high proportion (58 %) of cases
that were confirmed by haematology and or necropsy,
veterinary practitioners demonstrated a great commit-
ment to elucidate the previously unknown aetiology of
this disease.
The spectacular clinical signs that are most often seen
in affected calves, and the severe process of BNP are
very similar among cases. Therefore, it can be assumed
that affected farmers and their veterinarians are aware of
the disease pattern and that most of the calves included
in this study without disease confirmation likely did have
BNP. Some cases of BNP were probably missed at the
very beginning of the occurrence when farmers and
veterinarians were not aware of the disease or in case of
sudden death. Furthermore it is not possible to get any
information about subclinical cases of BNP within a
herd without blood sampling the calves, thus subclinical
BNP could not be taken into account.
Reichmann et al. BMC Veterinary Research  (2016) 12:220 Page 7 of 9
Because there are no advantages (e.g. compensation or
specific treatments and better prognoses for the calves
after disease diagnosis) for farmers and veterinarians in
confirming additional cases, the proportion of inves-
tigated cases will decline and reports on the occurrence
of BNP to official agencies will become less common
over the years.
Conclusions
The number of calves with BNP in Germany is higher
than officially assumed. Many cases have not been regis-
tered as PhV reports at the NPhVS, and we revealed a
remarkable underreporting of the disease.
The incidence of BNP varies considerably, not only
among federal states, but also among affected herds
within one area. Considerable financial losses can be as-
sumed, especially on farms with a high incidence.
Considering the whole bovine population of Germany,
the incidence of BNP is low, even when accounting
for the fact that many affected calves have not been
registered.
Due to the well-advanced clarification of the aetio-
pathogenesis of BNP and the suspension of the license
for PregSure BVD, the peak incidence for this disease
has passed. However, a few cases of BNP still occur. It is
likely that cases of BNP will occur until the last dam
vaccinated with PregSure BVD has left the farms.
Additional file
Additional file 1: Questionnaire. Farmers were interviewed by
telephone using this questionnaire. (DOCX 16 kb)
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